Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up of the tumour. In a retrospective analysis, we determined the molecular subtypes of breast cancer originally defined by expression microarrays by immunohistochemistry in tumours of patients who took...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannemann, J, Kristel, P, van Tinteren, H, Bontenbal, M, van Hoesel, Q G C M, Smit, W M, Nooij, M A, Voest, E E, van der Wall, E, Hupperets, P, de Vries, E G E, Rodenhuis, S, van de Vijver, M J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360599/
https://www.ncbi.nlm.nih.gov/pubmed/17088909
http://dx.doi.org/10.1038/sj.bjc.6603449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360599/
https://www.ncbi.nlm.nih.gov/pubmed/17088909
http://dx.doi.org/10.1038/sj.bjc.6603449

Ejemplares similares